We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

SPI-1005 Treatment in Severe COVID-19 Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04483973
Recruitment Status : Enrolling by invitation
First Posted : July 23, 2020
Last Update Posted : November 8, 2022
Information provided by (Responsible Party):
Sound Pharmaceuticals, Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : April 2023
Estimated Study Completion Date : April 2023